Categories: News

Real Time Medical Systems Welcomes Diana Smalley, FACHE, as Health System & ACO Advisor

BALTIMORE, Feb. 16, 2021 /PRNewswire/ — Real Time Medical Systems, the leading healthcare Interventional Analytics solution, is excited to welcome Diana “Di” Smalley, FACHE, to its team as an Advisor to Health Systems and Accountable Care Organizations (ACOs). In her new role, Smalley will work with Real Time’s Executive Team to advance acute care solution offerings in achieving post-acute interoperability to improve care coordination, enhance population health, and reduce total cost of care.

Smalley will advise on care coordination advancements of Real Time’s Interventional Analytics platform for acute care.

“We are honored to have Di join the Real Time team,” states Joan Neuscheler, Chief Executive Officer at Real Time. “Her extraordinary career as a renowned health system executive has helped to advance quality of care and improve care coordination across the continuum. We look forward to working with Di and drawing upon her visionary insights to continuously refine our solutions to meet evolving healthcare market demands.”

As an exemplary leader in healthcare management, Smalley is an active fellow with the American College of Healthcare Executives (ACHE) where she served as chairman, chairman elect, and immediate past chairman. Beginning her career as a bedside nurse, Smalley rose through the ranks to the c-suite in both non-profit and for-profit health systems. With over 30 years of senior-level executive experience, including the Regional President of Mercy Oklahoma where she oversaw 15 hospitals and more than 100 clinics, Smalley has dedicated her career to improving patient care. Recognized for her contributions in advancing care delivery, Smalley was honored by the ACHE with its highest honor, the Gold Medal Award, which identifies ACHE fellows who best exemplify leadership at the organizational, local, state, and national levels while improving healthcare services and community health beyond their organization.

“I am excited to continue working toward advancing care delivery with an organization such as Real Time, who truly cares about improving the quality of care of our senior communities,” states Smalley. “I look forward to contributing to Real Time’s continued growth as the company works to set new precedents in achieving post-acute interoperability and improved care coordination for ACOS and health systems nationwide.”

Smalley received her B.A. in biology from Midland Lutheran College and Master of Public Health from the University of Minnesota.

Press Contact

Keri DeSalvo
Vice President, Marketing
kdesalvo@realtimemed.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/real-time-medical-systems-welcomes-diana-smalley-fache-as-health-system–aco-advisor-301227507.html

SOURCE Real Time Medical Systems

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago